Steven Cohen's position in Palvella Therapeutics is currently worth $9.59M. That's 0.02% of their equity portfolio (735th largest holding). The first Palvella Therapeutics trade was made in Q3 2025. Since then Steven Cohen bought shares one more times and sold shares on one occasions. The stake costed the investor $4.07M, netting the investor a gain of 135% so far.